| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/03/2009 | US7485669 Blockade of sodium channels by phenol derivatives |
| 02/03/2009 | US7485663 dissolving in a solvent, precipitating crystal form by cooling the solution to about -20C |
| 02/03/2009 | US7485655 2-Aminothiazole allosteric enhancers of A1 adenosine receptors |
| 02/03/2009 | US7485647 2-aminoquinoline derivatives |
| 02/03/2009 | US7485642 Administering levosimendan or a salt thereof |
| 02/03/2009 | US7485639 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |
| 02/03/2009 | US7485638 Pyrimidine compounds |
| 02/03/2009 | US7485634 Methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of |
| 02/03/2009 | US7485628 Inhibition of STAT-1 |
| 02/03/2009 | US7485626 Biosynthesis of Dna ; cell proliferation; overlapping enzyme activation ; mixture of proteolytic enzyme and dipeptidyl peptidase inhibitors; autoimmune disease; antiinflammatory agents graft versus host diease |
| 02/03/2009 | US7485624 administering a neurotoxin, specifically a botulinum toxin, to treat disorders such as cardiac arrhythmias |
| 02/03/2009 | US7485429 Genetically engineered polypeptide comprising extracellular domain of integrin subunit alpha 11; marker or target of all types of cells; drugs, vaccines |
| 02/03/2009 | US7485327 For use in pharmaceuticals, dietetics and/or cosmetics; anticancer agents; for treatment of vision defects and periodontal disease |
| 02/03/2009 | CA2441613C Novel amlodipine camsylate and method for preparing thereof |
| 02/03/2009 | CA2425164C (4-acylaminopiperidin-1-yl)acetamides as neurokinin antagonists |
| 02/03/2009 | CA2420040C New phenylalanine derivatives |
| 02/03/2009 | CA2315050C Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof |
| 01/30/2009 | CA2712022A1 Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and a pharmaceutical composition comprising it - 026 |
| 01/29/2009 | WO2009015028A1 Substituted cyclohexenes |
| 01/29/2009 | WO2009014674A1 Heterocyclylamides as gut microsomal triglyceride transport protein inhibitors |
| 01/29/2009 | WO2009014217A1 Bicyclic pyrrole derivative |
| 01/29/2009 | WO2009013543A2 Targeted binging agents directed to kdr and uses thereof - 035 |
| 01/29/2009 | WO2009013334A1 Use of nor-bile acids in the treatment of arteriosclerosis |
| 01/29/2009 | WO2009013286A1 Organic compounds |
| 01/29/2009 | WO2009012901A2 Material compositions which comprise adult stem cells obtained from exocrine glandular tissue, in particular for use in regenerative medicine, e.g. for restoring injured or damaged myocardial tissue |
| 01/29/2009 | WO2009012650A1 Aryl pyrimidine derivatives, preparation methods and pharmaceutical uses thereof |
| 01/29/2009 | WO2009012647A1 Preparation methods of quinazoline derivatives and their pharmaceutical uses |
| 01/29/2009 | WO2009012573A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/29/2009 | WO2009012571A1 Tissue kallikrein for the treatment of diseases associated with amyloid protein |
| 01/29/2009 | WO2008149177A3 Marine lipid compositions and uses thereof |
| 01/29/2009 | WO2008129077A3 Crystalline 1-(cyclohexyloxycarbonyloxy) ethyl 1-((2'-cyanobiphenyl-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate and a process for its preparation |
| 01/29/2009 | WO2008112773A3 Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotension |
| 01/29/2009 | WO2008107211A3 Novel p2y12 receptor antagonists |
| 01/29/2009 | WO2008104278A8 Imidazo[1,2-a] pyridines and their use as pharmaceuticals |
| 01/29/2009 | WO2008085074A8 1, 3-dihydroimidazoles for treating cardiovascular disorders |
| 01/29/2009 | WO2007061661A4 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 01/29/2009 | US20090030080 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 01/29/2009 | US20090030077 Novel Fenofibrate Formulations and Related Methods of Treatment |
| 01/29/2009 | US20090030071 Treatment of Cardiovascular Disease in Mexican Americans Using Nebivolol |
| 01/29/2009 | US20090030052 Pharmaceutical tablet compositions containing irbesartan |
| 01/29/2009 | US20090030051 Inhibitors of IMPDH enzyme |
| 01/29/2009 | US20090030036 Nuclear receptor binding agents |
| 01/29/2009 | US20090030032 Bicyclic Compound, Production and Use Thereof |
| 01/29/2009 | US20090030023 Pyrimidine compounds and medicinal composition thereof |
| 01/29/2009 | US20090030015 Novel multi-cyclic compounds |
| 01/29/2009 | US20090029998 Thiazole Derivatives and Use Thereof |
| 01/29/2009 | US20090029995 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 01/29/2009 | US20090029994 Trisubstituted amine compound |
| 01/29/2009 | US20090029989 Substituted pyrazolopyrimidines |
| 01/29/2009 | US20090029986 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |
| 01/29/2009 | US20090029981 Substituted 4-phenylpiperidines |
| 01/29/2009 | US20090029978 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 01/29/2009 | US20090029965 Vasopressin V1a Antagonists |
| 01/29/2009 | US20090029957 8-beta-substituted estratrienes as selectively active estrogens |
| 01/29/2009 | US20090029922 Use of S1P receptor agonists in heart diseases |
| 01/29/2009 | US20090029912 Method of enhancing proliferation and/or survival of mesenchymal precursor cells (mpc) |
| 01/29/2009 | US20090029908 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS |
| 01/29/2009 | US20090029904 Compositions and methods for treatment of insulin-resistance diseases |
| 01/29/2009 | US20090029444 Novel recombinant anticoagulant proteins |
| 01/29/2009 | US20090029400 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/29/2009 | US20090028959 Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries |
| 01/29/2009 | US20090028943 Pharmaceutical compositions |
| 01/29/2009 | US20090028927 Poly(vinyl alcohol) - bacterial cellulose nanocomposite |
| 01/29/2009 | US20090028904 Novel cochleate formulations |
| 01/29/2009 | US20090028882 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/29/2009 | US20090028867 Antagonists Specific For Denatured Collagen And Methods Of Using Same |
| 01/29/2009 | US20090028859 Bispecific antibodies that bind to vegf receptors |
| 01/29/2009 | US20090028852 Roles For Dual Endothelin-1/Angiotensin II Receptor (DEAR) In Hypertension and Angiogenesis |
| 01/29/2009 | DE102007035367A1 Substituierte Aryloxazole und ihre Verwendung Substituted Aryloxazole and their use |
| 01/29/2009 | DE102007034679A1 Materialzusammensetzungen, welche aus exokrinem Drüsengewebe erhaltene adulte Stammzellen enthalten, insbesondere zur Verwendung in der Regenerationsmedizin, zB zur Wiederherstellung von verletztem oder geschädigtem Myokardgewebe Material compositions containing obtained from exocrine glandular tissue of adult stem cells, particularly for use in regenerative medicine, for example, to restore injured or damaged myocardial tissue |
| 01/29/2009 | CA2694396A1 Targeted binding agents directed to kdr and uses thereof - 035 |
| 01/29/2009 | CA2693921A1 Tissue kallikrein for the treatment of diseases associated with amyloid protein |
| 01/29/2009 | CA2693290A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/28/2009 | EP2019098A1 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor |
| 01/28/2009 | EP2018872A1 Pharmaceutical product |
| 01/28/2009 | EP2018855A1 Pharmaceutical agent |
| 01/28/2009 | EP2018853A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor |
| 01/28/2009 | EP2018376A1 Benzylamine derivatives as cetp inhibitors |
| 01/28/2009 | EP2018186A2 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof |
| 01/28/2009 | EP2018165A1 Fgf-peceptor agonist dimeric compounds |
| 01/28/2009 | EP2018152A2 Pre-mixed, ready-to-use pharmaceutical compositions |
| 01/28/2009 | EP1541672B1 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/28/2009 | EP1470826B1 Decoy-containing pharmaceutical compositions for the treatment of aneurysms |
| 01/28/2009 | EP1207755B1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation |
| 01/28/2009 | EP1177181B1 Substituted bicyclic compounds |
| 01/28/2009 | EP1073416B1 Use of inhaled no as anti-inflammatory agent |
| 01/28/2009 | CN101356174A Indol-3-yl-carbonyl-spiro-piperidine derivatives |
| 01/28/2009 | CN101356156A Aspartic protease inhibitors |
| 01/28/2009 | CN101355954A Therapeutic agent for metabolic syndrome and food containingthe therapeutic agent |
| 01/28/2009 | CN101353687A Melissa powder peptides having angiotensin transferase inhibitory activity and preparation thereof |
| 01/28/2009 | CN101353346A Puerarin amino acid ester derivative and medicine use thereof |
| 01/28/2009 | CN101353294A Separation and purification method of high-content resveratrol |
| 01/28/2009 | CN101352562A Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases and method for preparing the same |
| 01/28/2009 | CN101352540A Nutritive health product and preparation method thereof |
| 01/28/2009 | CN101352524A Powder for treating hemorrhoid |
| 01/28/2009 | CN101352507A Capsules for treating angina pectoris |
| 01/28/2009 | CN101352492A Medicament composition for treating cardio-cerebrovascular disease and regulating blood fat |
| 01/28/2009 | CN101352474A Uses of prickly pear and prickly pear polysaccharide in preparing medicament or health products |
| 01/28/2009 | CN101352466A Chinese medicinal composition and uses thereof |
| 01/28/2009 | CN101352439A Composition injection containing tetrandrine and preparation method thereof |